Relay Therapeutics, Inc.
About
13.90USD-0.53 -3.67%
Closed • Updated at 08:19 GMT+00:00Market Cap$2.66B
Volume3.95M
Beta2.08
RSI55.64
Gross Margin73.28%
Relay Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 19 2026
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
May 5 2026
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
Apr 29 2026
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
Apr 27 2026
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
Apr 2 2026
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Recent Videos
Relay Therapeutics Initial Clinical Data for Zovegalisib in Vascular Anomalies | May 19, 2026
May 20, 2026
RLAY Stock Analysis | Is Zovegalisib a Blockbuster?
May 20, 2026
Chewy Sinks, DoorDash Drops, Relay Therapeutics Rises | Stock Movers
May 19, 2026
RLAY Phase 3 Breast Cancer Trial: My Key Insight from the 8-K
Apr 27, 2026
Community Chat
Ask AI
Try asking